Menopausal women on hormone replacement therapy may be at elevated risk of dementia and Alzheimer’s disease, according to a major new study published Wednesday in The British Medical Journal.
The increased risk was seen in both short-term users around the age of menopause (55 or younger), as well as in long-term users. More research is needed to determine if hormone replacement therapy is to blame, the authors wrote, adding that women who require the treatment may be predisposed to dementia for reasons yet unknown.
